Abstract:BACKGROUND:Treatments that target cancer stem cells play an important role in the controlling and eliminating of tumor initiation as well as in development, progression, and chemotherapy/radiotherapy resistance. In our previous study, we cultured and harvested human laryngeal cancer stem cells (CSCs) and applied microRNA biochips to screen differentially expressed miRNAs that were related to radiation tolerance in irradiated human laryngeal CSCs. According to the predicted genes and pathways of differential miRNAs target, down-regulated expression of hsa-miR-138-2-3p under radiation was thought to play a key role in enhancing the radio-sensitivity in human laryngeal squamous cancer stem cells. METHOD:To investigate the radiational enhancement of hsa-miR-138-2-3p, we transfected hsa-miR-138-2-3p mimics that were synthesized based on the sequences of hsa-miR-138-2-3p in vitrointo human laryngeal CSCs (Hep-2, M2e, and TU212 cell lines) to make hsa-miR-138-2-3p overexpressed, and the tumorous specialities of CSCs, like cell proliferation, invasion, apoptosis, cell cycle arrest, and DNA damage were evaluated by CCK-8 assay, clone formation assay, invasion assay, flow cytometry, and comet assay. Furthermore, we explored the signal transduction pathways that regulated the cancer stem cell initiation, development, invasion, apoptosis and cell cycle arrest, which were controlled by hsa-miR-138-2-3p. RESULT:Overexpressed hsa-miR-138-2-3p played a key role in many anti-cancer biological processes in human laryngeal CSCs: (1) it decreased laryngeal CSCs proliferation and invasion in response to radiotherapy; (2) it increased the proportion of early and late apoptosis in laryngeal CSCs after radiation, raised G1 phase arrest in laryngeal CSCs after radiation, and decreased the proportion of S stage cells of cell cycle that were related to radio-resistance in laryngeal CSCs; (3) it down-regulated the expression of β-catenin in Wnt signal pathway that was related to the tolerance of laryngeal CSCs to radiotherapy; (4) it down-regulated the expression of YAP1 in Hippo signal pathway that regulated cell proliferation, invasion and apoptosis; (5) it up-regulated the expression of p38 and JNK1 in MAPK signal pathway that was concerned to radio-sensitivity. CONCLUSION:In the present study, it was found that hsa-miR-138-2-3p regulated the Wnt/β-catenin pathways, the Hippo/YAP1 pathways, and the MAPK/p38/JNK1 pathways that were involved in cell proliferation, invasion, apoptosis, cell cycle arrest, radio-resistance and radio-sensitivity in laryngeal CSCs. These results will be useful for a better understanding of the cell biology of hsa-miR-138-2-3p in laryngeal CSCs, and for serving hsa-miR-138-2-3p as a promising biomarker and as a target for diagnosis and for novel anti-cancer therapies for laryngeal cancers.

miR-509 inhibits cancer stemness properties in oral carcinomas via directly targeting PlK1

MiR-509-3-5p Causes Aberrant Mitosis and Anti-Proliferative Effect by Suppression of PLK1 in Human Lung Cancer A549 Cells

MicroRNA expression profile of colon cancer stem-like cells in HT29 adenocarcinoma cell line.

Radiosensitization effect of hsa-miR-138-2-3p on human laryngeal cancer stem cells.

Involvement of Polo-like Kinase 1 (plk1) in Quiescence Regulation of Cancer Stem-Like Cells of the Gastric Cancer Cell Lines

MiR-4513 Mediates the Proliferation and Apoptosis of Oral Squamous Cell Carcinoma Cells Via Targeting CXCL17

miR-296-5p suppresses cell viability by directly targeting PLK1 in non-small cell lung cancer.

MicroRNA-134 Inhibits Tumor Stem Cell Migration and Invasion in Oral Squamous Cell Carcinomas Via Downregulation of PI3K-Akt Signaling Pathway by Inhibiting LAMC2 Expression.

Mir-593-5p Inhibit Cell Proliferation by Targeting PLK1 in Non Small Cell Lung Cancer Cells

MiR-506 Suppresses Liver Cancer Angiogenesis Through Targeting Sphingosine Kinase 1 (SPHK1) Mrna

Microrna-1 Down-Regulates Proliferation And Migration Of Breast Cancer Stem Cells By Inhibiting The Wnt/Beta-Catenin Pathway

Downregulation of DNMT3A by miR-708-5p Inhibits Lung Cancer Stem Cell-like Phenotypes through Repressing Wnt/beta-catenin Signaling

MicroRNA-214-3p Inhibits the Stem-Like Properties of Lung Squamous Cell Cancer by Targeting YAP1

Microrna-34a Suppresses the Breast Cancer Stem Cell-Like Characteristics by Downregulating Notch1 Pathway

MicroRNA-433 inhibits oral squamous cell carcinoma cells by targeting FAK.

Activation of the miR-371/372/373 miRNA Cluster Enhances Oncogenicity and Drug Resistance in Oral Carcinoma Cells

MiR-199a-5p represses the stemness of cutaneous squamous cell carcinoma stem cells by targeting Sirt1 and CD44ICD cleavage signaling

RGS1 targeted by miR-191-3p inhibited the stemness properties of esophageal cancer cells by suppressing CXCR4/PI3K/AKT signaling

MiR-503 targets PI3K p85 and IKK-β and suppresses progression of non-small cell lung cancer.

MiR-5100 Increases the Cisplatin Resistance of the Lung Cancer Stem Cells by Inhibiting the Rab6

MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway